Dataset Information


Desaturase Activity and the Risk of Type 2 Diabetes and Coronary Artery Disease: A Mendelian Randomization Study.

ABSTRACT: Estimated ?5-desaturase (D5D) and ?6-desaturase (D6D) are key enzymes in metabolism of polyunsaturated fatty acids (PUFA) and have been associated with cardiometabolic risk; however, causality needs to be clarified. We applied two-sample Mendelian randomization (MR) approach using a representative sub-cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study and public data from DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) and Coronary ARtery DIsease Genome wide Replication and Meta-analysis (CARDIoGRAM) genome-wide association studies (GWAS). Furthermore, we addressed confounding by linkage disequilibrium (LD) as all instruments from FADS1 (encoding D5D) are in LD with FADS2 (encoding D6D) variants. Our univariable MRs revealed risk-increasing total effects of both, D6D and D5D on type 2 diabetes (T2DM) risk; and risk-increasing total effect of D6D on risk of coronary artery disease (CAD). The multivariable MR approach could not unambiguously allocate a direct causal effect to either of the individual desaturases. Our results suggest that D6D is causally linked to cardiometabolic risk, which is likely due to downstream production of fatty acids and products resulting from high D6D activity. For D5D, we found indication for causal effects on T2DM and CAD, which could, however, still be confounded by LD.


PROVIDER: S-EPMC7469057 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6447447 | BioStudies
2017-01-01 | S-EPMC5486258 | BioStudies
2020-01-01 | S-EPMC7243306 | BioStudies
1000-01-01 | S-EPMC4804219 | BioStudies
2018-01-01 | S-EPMC5996566 | BioStudies
2019-01-01 | S-EPMC6351138 | BioStudies
2016-01-01 | S-EPMC4689341 | BioStudies
2013-01-01 | S-EPMC3588878 | BioStudies
1000-01-01 | S-EPMC5018866 | BioStudies
2016-01-01 | S-EPMC4811535 | BioStudies